Alternative Data for MetLife
About MetLife
MetLife Inc provides life insurance, annuities, employee benefits and asset management in the United States, Japan, Latin America, Asia, Europe and the Middle East.
| Price | $76.69 |
| Target Price | Sign up |
| Volume | 3,260,000 |
| Market Cap | $50.4B |
| Year Range | $72.93 - $82.61 |
| Dividend Yield | 2.89% |
| PE Ratio | 14.28 |
| Analyst Rating | 91% buy |
| Earnings Date | February 4 '26 |
| Industry | Insurance |
In the news
MetLife Inc. stock underperforms Friday when compared to competitorsJanuary 23 - MarketWatch |
|
MetLife Inc. stock outperforms competitors on strong trading dayJanuary 21 - MarketWatch |
|
MetLife Inc. stock underperforms Tuesday when compared to competitorsJanuary 20 - MarketWatch |
|
 |
3 Reasons to Avoid MET and 1 Stock to Buy InsteadJanuary 19 - Yahoo |
MetLife Inc. stock underperforms Monday when compared to competitorsJanuary 12 - MarketWatch |
|
|
Will MetLife’s (MET) New MIM Segment and Capital Returns Reshape Its Core Investment Narrative?January 11 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 16.9B | 13.9B | 2.94B | 896M | 1.48B | 2.370 |
| Q2 '25 | 17.2B | 12.6B | 4.54B | 729M | 1.25B | 2.020 |
| Q1 '25 | 18.3B | 13.5B | 4.72B | 945M | 1.61B | 1.960 |
| Q4 '24 | 18.4B | 13.6B | 4.86B | 1.27B | 1.64B | 2.090 |
| Q3 '24 | 18.3B | 12.9B | 5.45B | 1.34B | 2.25B | 1.950 |
Insider Transactions View All
| PAPPAS BILL filed to sell 66,744 shares at $80.5. May 13 '25 |
| DEBEL MARLENE filed to sell 108,507 shares at $82.9. December 17 '24 |
| Khalaf Michel filed to sell 500,799 shares at $82.8. December 17 '24 |
| PAPPAS BILL filed to sell 57,768 shares at $72.3. March 20 '24 |
| TADROS RAMY filed to sell 146,981 shares at $71.9. March 14 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
AllstateALL |
$194.77 0.6% | 45 |
 |
ProgressivePGR |
$208.08 0% | 46 |
 |
AflacAFL |
$108.38 0.5% | 43 |
 |
LemonadeLMND |
$87.75 2.4% | 62 |
 |
Oscar HealthOSCR |
$14.88 5.2% | 66 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Ritchie Torres |
Aug 21, 25 | Sell | $1K - $15K |
| Ro Khanna |
Jul 10, 25 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Jun 5, 24 | Sell | $1K - $15K |
Read more about MetLife (MET) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, app downloads, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
FAQ - MetLife
The Market Cap of MetLife is $50.4B.
As of today, MetLife's PE (Price to Earnings) ratio is 14.28.
MetLife will report its next earnings on February 4 '26.
Currently, the price of one share of MetLife stock is $76.69.
The MET stock price chart above provides a comprehensive visual representation of MetLife's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling MetLife shares. Our platform offers an up-to-date MET stock price chart, along with technical data analysis and alternative data insights.
Yes, MetLife (MET) offers dividends to its shareholders, with a dividend yield of 2.89%. This dividend yield represents MetLife's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering MetLife in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of MetLife are Allstate, Progressive, Aflac, Lemonade, and Oscar Health.
